Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine

John D. Fryer, Ronald J. Lukas

Research output: Contribution to journalArticlepeer-review

268 Scopus citations

Fingerprint Dive into the research topics of 'Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine'. Together they form a unique fingerprint.

Medicine & Life Sciences